Maastricht University Medical Center
Wageningen University and Research Centre
This study evaluates the ability of encapsulation of orally applied lipids in a yoghurt snack to modify ad libitum food intake and satiety, without GI symptoms. Every subject receives two treatments (active, and placebo) on two different days, following a randomized cross-over design.
- : Active yoghurtActive yoghurt (containing encapsulated lipid) will be ingested after a standardized breakfast, and subsequently satiety and food intake will be measured.
- : Placebo yoghurtPlacebo yoghurt (containing non-encapsulated lipid) will be ingested after a standardized breakfast, and subsequently satiety and food intake will be measured.
|Ages eligible for Study||18 Years to 65 Years|
|Genders eligible for Study||All|
|Accepts Healthy Volunteers||Accepts Healthy Volunteers|
- BMI between 25-30 kg/m2
- Voluntary participation
- Milk (-protein or lactose)- allergy/intolerance
- History of serious GI complaints/surgeries
- Pregnancy, lactation
- Excessive alcohol consumption (>20 per week)
- Abnormal eating behaviour
- Intention to stop smoking
- Reported unexplained weight loss or gain in the month prior to screening
- Self-admitted HIV-positive state
- Maastricht UniversityMaastricht, Netherlands
23 January, 2017
10 April, 2017